Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

The significance of vascular endothelial growth factor(VEGF) in children with asthma and pneumonia

소아 천식과 폐렴에서 혈청 vascular endothelial growth factor 농도의 의의

  • Choi, Seong Hwan (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shim, Jung Yeon (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Yoo, Myung Hwan (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Kim, Deok Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shim, Jae Won (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jung, Hye Lim (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Park, Moon Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 최성환 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 심정연 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 유명환 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 김덕수 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 심재원 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 정혜림 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 박문수 (성균관대학교 의과대학 강북삼성병원 소아과)
  • Received : 2005.09.15
  • Accepted : 2005.10.19
  • Published : 2006.02.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Vascular endothelial growth factor(VEGF) is a key cytokine for controlling vascular permeability and angiogenesis, which is one of the major findings in airway remodeling. However, it is not well known if it is associated with acute lower respiratory tract disease such as lobar pneumonia. The aim of this study is to compare serum VEGF levels in patients with asthma according to its severity and duration of cough, and to compare its levels with children with lobar pneumonia. Methods : Using a sandwich enzyme-linked immunosorbent assay, the serum VEGF levels were measured in 16 mild asthmatics, 14 moderate to severe asthmatics, six children with lobar pneumonia, and 22 control subjects. The asthmatics were also classified into three groups according to the duration of cough. Serum VEGF levels were compared in each group. Results : Serum VEGF levels were significantly increased in the children with moderate to severe asthma and lobar pneumonia compared to the children with mild asthma and control subjects. Serum VEGF levels were higher in children with chronic coughs of more than two weeks than in children with coughs lasting less than two weeks. Serum levels of VEGF showed positive correlations with blood platelet and white blood cell counts. Conclusion : VEGF increased according to the severity of asthma and duration of cough in children with asthma. It may play an important role not only in chronic airway inflammation, but also in the acute inflammation in children with lower respiratory tract disease.

목 적 : 천식은 기도의 만성 염증성 질환으로 기도개형은 천식에서 가장 중요한 병태생리이다. 혈관의 신생 및 혈관투과성을 증가시키는 것으로 알려진 VEGF가 천식의 중증도와 기침의 지속기간에 따라 차이가 있는지 알아보고, 폐렴과 같은 급성 하기도 질환에서도 증가하는지 알아보고자 하였다. 방 법 : 2001년 1월부터 2002년 1월까지 강북삼성병원 소아과에 천식 및 폐렴으로 내원한 36명의 환아와 건강검진을 위해 소아과 외래를 방문한 건강한 어린이 22명을 대상으로 하였다. 천식 환아는 중증도에 따라 경증 천식군과 중등증 및 중증 천식의 두 군으로 나누고, 또한 내원 시까지의 기침의 지속기간에 따라 2주 미만, 2주에서 4주, 4주 이상의 세 군으로 분류한 후 각각 혈청 VEGF 농도를 비교하였으며, 혈소판 및 백혈구수, CRP, IgE 농도, 총호산구수, 대상군의 나이와의 상관관계를 조사하였다. 결 과 : 평균 혈청 VEGF 농도는 경증 천식군, 중등증 및 중증 천식군, 폐렴군, 대조군에서 각각 $278.4{\pm}191.6pg/mL$, $751.6{\pm}534.2pg/mL$, $775.6{\pm}340.0pg/mL$, $311.2{\pm}198.1pg/mL$로 중등증 및 중증 천식군과 폐렴군에서 경증 천식군 및 대조군보다 혈청 VEGF 농도가 유의하게 높았다(P<0.05). 기관지 천식을 앓고 있는 환아 중 기침 기간에 따라 혈청 VEGF 농도를 비교해 본 결과 2주 이상 4주 이하 동안 기침을 한 군 및 4주 이상 기침을 한 군에서 혈청 VEGF 농도는 각각 $709.2{\pm}589.3pg/mL$, $896.9{\pm}594.9pg/mL$로 2주 미만 기침을 한 그룹의 $307.1{\pm}198.4pg/mL$에 비하여 의미있게 높았다(P<0.05). 혈청 VEGF 농도와 혈소판 수치 및 백혈구수와는 양의 상관관계를 보였으며(P<0.05), CRP, IgE 농도, 총호산구수 및 대상군의 나이와는 의미 있는 상관관계가 없었다. 결 론 : 혈청 VEGF는 기관지 천식에서 중증도 및 염증의 지속기간과 연관이 있으며, 급성 하기도 질환의 급성 염증반응에도 중요한 역할을 한다.

Keywords

References

  1. Cotran R, Kumur V, Robin S. Inflammation and repair. In : Cotran R, Kumur V, Robin S, editors. Robbins pathologic basis of disease. 4th ed. Philadelphia : WB Saunders Co, 1989:39-87
  2. Pohunek P, Roche WR, Turzikova J, Kurdman J, Warner J. Eosionphilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Respir J 1997;10:160S
  3. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39
  4. Unger L. Pathology of bronchial asthma with five autopsy reports. South Med J 1945;38:513-23 https://doi.org/10.1097/00007611-194508000-00004
  5. Walzer I, Frost TT. Death occurring in bronchial asthma: a report of five cases. J Allergy 1952;23:204-14 https://doi.org/10.1016/0021-8707(52)90018-X
  6. Dunnill MS. The pathology of asthma, with special references to changes in the bronchial mucosa. J Clin Pathol 1960;13:27-33 https://doi.org/10.1136/jcp.13.1.27
  7. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1922;30:689-760 https://doi.org/10.1001/archinte.1922.00110120002001
  8. Macdonald IG. The local and constitutional pathology of bronchial asthma. Ann Intern Med 1932;6:253-77 https://doi.org/10.7326/0003-4819-6-2-253
  9. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989;139:242-6 https://doi.org/10.1164/ajrccm/139.1.242
  10. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993;147:405-10 https://doi.org/10.1164/ajrccm/147.2.405
  11. Bai TR, Cooper J, Koelmeyer T, Pare PD, Weir TD. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med 2000;162:663-9 https://doi.org/10.1164/ajrccm.162.2.9907151
  12. Okazawa M, Muller N, McNamara AE, Child S, Verburgt L, Pare PD. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit Care Med 1996;154:1557-62 https://doi.org/10.1164/ajrccm.154.5.8912780
  13. Awadh N, Muller NL, Park CS, Abbound RT, FitzGerald JM. Airway wall thickness in patients with near fatal asthma and control groups : assessment with high resolution computed tomographic scanning. Thorax 1998;53:248-53 https://doi.org/10.1136/thx.53.4.248
  14. Niimi A, Matsumoto H, Amitani R, Nakano Y, Mishima M, Minakuchi M, et al. Airway wall thickness in asthma assessed by computed tomography; Relation to clinical indices. Am J Respir Crit Care Med 2000;162:1518-23 https://doi.org/10.1164/ajrccm.162.4.9909044
  15. McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 2000;161: 1877-80 https://doi.org/10.1164/ajrccm.161.6.9905022
  16. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301 https://doi.org/10.1067/mai.2001.111928
  17. The Korean Academy of Pediatric Allergy and Respiratory Disease. The guideline for diagnosis and management of childhood asthma. 2nd ed. Seoul : Sowha Co, 1999:5-87
  18. Busse W, Elias J, Sheppard D, Banks-Schegel S. Airway remodeling and repair. Am J Respir Crit Care Med 1999; 160:1035-42 https://doi.org/10.1164/ajrccm.160.3.9902064
  19. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma : from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720-45 https://doi.org/10.1164/ajrccm.161.5.9903102
  20. Stevenson EC, Turner G, Heaney LG. Schock BC, Taylor R, Gallagher T, et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy 1997;27:1027-35 https://doi.org/10.1111/j.1365-2222.1997.tb01254.x
  21. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-8 https://doi.org/10.1164/ajrccm.160.3.9812110
  22. Ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001;164:744-8 https://doi.org/10.1164/ajrccm.164.5.2011026
  23. Leckie MJ, Ten Brinke A, Khan J. Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking mon oclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356: 2144-8 https://doi.org/10.1016/S0140-6736(00)03496-6
  24. Chaudhuri R, McMahon AD, Thomson LJ, Macleod KJ, McSharry CP, Livingston E, et al. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol 2004;113:1063-70 https://doi.org/10.1016/j.jaci.2004.03.019
  25. Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999;85:178-87 https://doi.org/10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7
  26. Nishigaki Y, Fujiuchi S, Yamazaki Y, Matsumoto H, Takeda A, Fujita Y, et al. Increased vascular endothelial growth factor in acute eosinophilic pneumonia. Eur Respir J 2003;21:774-8 https://doi.org/10.1183/09031936.03.00085903
  27. Gaudryy M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153-61